Cocrystal Pharma Inc (STU:8CC)
€ 1.96 -0.01 (-0.51%) Market Cap: 20.23 Mil Enterprise Value: 9.68 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 36/100

Cocrystal Pharma Inc at Noble Capital Markets Takeaway Series on Channelchek- J.P. Morgan Healthcare Conference Transcript

Jan 26, 2023 / 04:00PM GMT
Release Date Price: €2.71 (+14.62%)
Unidentified Participant

Welcome to the Channelchek Takeaway Series. This program is provided for informational purposes only. And none of its content should be interpreted as a recommendation or solicitation to buy or sell securities. Investment decisions must be made by you or with the support of your financial advisor. The complete disclosure statement follows each presentation.

Cocrystal Pharma, NASDAQ ticker symbol COCP, is a clinical-stage biotechnology company, discovering and developing novel antiviral therapeutics that target the replication process of coronaviruses, influenza viruses, noroviruses, and hepatitis C viruses.

Joining us today is Cocrystal Pharma's CFO and Co-CEO James Martin. Following a brief introduction to the company, James will be joined by Noble Senior Research Analyst, Robert LeBoyer, for the Q&A.

Take it away, James.

James Martin
Cocrystal Pharma, Inc. - Interim Co-CEO & CFO

Thank you for having us on your show. I appreciate it -- appreciate the audience's interest in Cocrystal.

I have a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot